Abstract:Mitophagy is the intracellular recycling system that disposes damaged/inefficient mitochondria and allows biogenesis of new organelles to ensure mitochondrial quality is optimized. Dysfunctional mitophagy has been implicated in human aging and diseases. Multiple evolutionarily selected, redundant mechanisms of mitophagy have been identified, but their specific roles in human health and their potential exploitation as therapeutic targets are unclear. Recently, the characterization of the endosomal-lysosomal system has revealed additional mechanisms of mitophagy and mitochondrial quality control that operate via the production of mitochondria-derived vesicles (MDVs). Circulating MDVs can be isolated and characterized to provide an unprecedented opportunity to study this type of mitochondrial recycling in vivo and to relate it to human physiology and pathology. Defining the role of MDVs in human physiology, pathology, and aging is hampered by the lack of standardized methods to isolate, validate, and characterize these vesicles. Hence, some basic questions about MDVs remain unanswered. While MDVs are generated directly through the extrusion of mitochondrial membranes within the cell, a set of circulating extracellular vesicles leaking from the endosomal-lysosomal system and containing mitochondrial portions have also been identified and warrant investigation. Preliminary research indicates that MDV generation serves multiple biological roles and contributes to restoring cell homeostasis. However, studies have shown that MDVs may also be involved in pathological conditions. Therefore, further research is warranted to establish when/whether MDVs are supporting disease progression and/or are extracting damaged mitochondrial components to alleviate cellular oxidative burden and restore redox homeoastasis. This information will be relevant for exploiting these vesicles for therapeutic purpose. Herein, we provide an overview of preclinical and clinical studies on MDVs in aging and associated conditions and discuss the interplay between MDVs and some of the hallmarks of aging (mitophagy, inflammation, and proteostasis). We also outline open questions on MDV research that should be prioritized by future investigations.

Extracellular release in the quality control of the mammalian mitochondria

Mitophagy Receptors Sense Stress Signals and Couple Mitochondrial Dynamic Machinery for Mitochondrial Quality Control.

Mitophagy, Mitochondrial Homeostasis, and Cell Fate

Mitophagy and Quality Control Mechanisms in Mitochondrial Maintenance

Quality control of mitochondria involves lysosomes in multiple definitive ways

The Release and Transmission of Amyloid Precursor Protein Via Exosomes

Biogenesis and secretion of mitovesicles, small extracellular vesicles of mitochondrial origin at the crossroads between brain health and disease

Quality control of mitochondria: protection against neurodegeneration and ageing

Mitochondrial Transfer Between Cell Crosstalk - An Emerging Role in Mitochondrial Quality Control

Generation and Release of Mitochondrial-Derived Vesicles in Health, Aging and Disease

Quality control of the mitochondrial proteome

Mitochondrial quality control and communications with the nucleus are important in maintaining mitochondrial function and cell health

Mitochondria Organize The Cellular Proteostatic Response And Promote Cellular Senescence

Sensing, signaling and surviving mitochondrial stress

Lysosomal Exocytosis, Exosome Release and Secretory Autophagy: The Autophagic- and Endo-Lysosomal Systems Go Extracellular

Cellular quality control by the ubiquitin-proteasome system and autophagy

Molecular cross talk among the components of the regulatory machinery of mitochondrial structure and quality control

Mitochondria break free: Mitochondria-derived vesicles in aging and associated conditions

Mitochondrial quality control in human health and disease

On mitochondrial quality control regulated by Bcl-2 family

Lysosomal quality control: molecular mechanisms and therapeutic implications